Everpar Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
CRM
VNIM
CNB
Everpar Advisors's LLY Position: Q2 2026 in Review
Everpar Advisors increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $104K and bringing the position to 2,780 shares worth $3.33M. The position accounts for 0.95% of the portfolio, ranked #23.
Everpar Advisors first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Everpar Advisors held 2,780 shares of Eli Lilly worth $3.33M as of Q2 2026.
- Everpar Advisors bought 102 Eli Lilly shares in Q2 2026, an estimated $104K.
- Eli Lilly made up 0.95% of Everpar Advisors's portfolio in Q2 2026, its #23 holding.
- Everpar Advisors first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.